PFS Partners’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.89K Hold
21
﹤0.01% 522
2025
Q4
$1.87K Hold
21
﹤0.01% 523
2025
Q3
$2.05K Hold
21
﹤0.01% 503
2025
Q2
$1.9K Hold
21
﹤0.01% 463
2025
Q1
$2.36K Hold
21
﹤0.01% 388
2024
Q4
$2.2K Hold
21
﹤0.01% 400
2024
Q3
$2.25K Hold
21
﹤0.01% 401
2024
Q2
$2.26K Hold
21
﹤0.01% 389
2024
Q1
$2.75K Hold
21
﹤0.01% 398
2023
Q4
$2.54K Hold
21
﹤0.01% 397
2023
Q3
$2.34K Hold
21
﹤0.01% 397
2023
Q2
$3.04K Hold
21
﹤0.01% 397
2023
Q1
$2.69K Hold
21
﹤0.01% 317
2022
Q4
$2.65K Hold
21
﹤0.01% 303
2022
Q3
$2.17K Hold
21
﹤0.01% 300
2022
Q2
$2.17K Hold
21
﹤0.01% 293
2022
Q1
$2.64K Sell
21
-1
-5% -$121 ﹤0.01% 298
2021
Q4
$2.62K Buy
+22
New +$2.88K ﹤0.01% 297

Other funds holding ZBH

PFS Partners's ZBH Position: Q1 2026 in Review

PFS Partners held its Zimmer Biomet (ZBH) position steady in Q1 2026 at 21 shares worth $1.89K. The position accounts for ﹤0.01% of the portfolio, ranked #522.

PFS Partners first reported a position in ZBH in Q4 2021 and has held it in 18 quarters since. The position peaked at $3.04K in Q2 2023. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • PFS Partners held 21 shares of Zimmer Biomet worth $1.89K as of Q1 2026.
  • PFS Partners left its Zimmer Biomet share count unchanged in Q1 2026.
  • Zimmer Biomet made up ﹤0.01% of PFS Partners's portfolio in Q1 2026, its #522 holding.
  • PFS Partners first reported a position in Zimmer Biomet in Q4 2021 and has held it in 18 quarters since.
  • PFS Partners's Zimmer Biomet position peaked at $3.04K in Q2 2023.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on PFS Partners's 13F filing for Q1 2026, filed 9 Apr 2026.